Salinas Sánchez A S, Moreno Avilés J, García Hernández J A, Gómez Gómez G A, Martínez Pertusa P, Server Falgas G
Actas Urol Esp. 1989 May-Jun;13(3):177-80.
Surface vesical tumors constitute 80% of transitional cell tumors. They are neoplasms of slow evolution, but characterized by their tendency to recur and progress in time. The prognostic factors, as regards recurrence and progression, are going to depend on a series of macroscopic or microscopic anatomic characteristics. We present our observations on some prognostic aspects in surface vesical carcinoma obtained from a study of 250 patients. By way of conclusion, from our observations we may infer that neither age, nor sex nor location, save in the case of patients under the age of 40, have prognostic value in the evolution of the primary tumor, which will be noticeably better (lower percentage of relapses and longer illness-free period) in patients with a single tumor of low grade and state, and in general in patients receiving intravesical prophylactic chemotherapy treatment, and no difference is found between thio-tepa and adriamycin.
浅表性膀胱肿瘤占移行细胞肿瘤的80%。它们是缓慢发展的肿瘤，但具有随时间复发和进展的倾向。关于复发和进展的预后因素将取决于一系列宏观或微观解剖特征。我们展示了对250例患者的研究中获得的浅表性膀胱癌一些预后方面的观察结果。作为结论，从我们的观察中可以推断，年龄、性别和肿瘤位置在原发性肿瘤的发展中均无预后价值，但40岁以下患者除外。对于低级别、低分期的单发肿瘤患者，以及一般接受膀胱内预防性化疗的患者，其原发性肿瘤的预后明显更好（复发率更低，无病生存期更长），且噻替派和阿霉素之间未发现差异。
